Christoph Nössing

Christoph Nössing

Auto-generated profile, based on publicly available information

Christoph Nössing

Garscube Estate

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 January 2022 in Science Advances
Verified
Journal Article
Open access
Jelena KrsticJelena Krstic
Jelena Krstic
IRIsabel Reinisch
Isabel Reinisch
KSKatharina Schindlmaier
Katharina Schindlmaier
MGMarkus Galhuber
Markus Galhuber
ZRZina Riahi
Zina Riahi
Prokesch AndreasProkesch Andreas
Prokesch Andreas
Cancer cells voraciously consume nutrients to support their growth, exposing metabolic vulnerabilities that can be therapeutically exploited. Here, we show in hepatocellular carcinoma (HCC) cells, xenografts, and patient-derived organoids that fasting improves sorafenib efficacy and acts synergistically to sensitize sorafenib-resistant HCC. Mechanistically, sorafenib acts noncanonically as an inhibitor of mitochondrial respiration, causing resistant cells to depend on glycolysis for survival. Fasting, through reduction in glucose and impeded AKT/mTOR signaling, prevents this Warburg shift. Regulating glucose transporter and proapoptotic protein expression, p53 is necessary and sufficient for the sorafenib-sensitizing effect of fasting. p53 is also crucial for fasting-mediated improvement of sorafenib efficacy in an orthotopic HCC mouse model. Together, our data suggest fasting and sorafenib as rational combination therapy for HCC with intact p53 signaling. As HCC therapy is currently severely limited by resistance, these results should instigate clinical studies aimed at improving therapy response in advanced-stage HCC.

4 June 2021 in Science Advances
Verified
Journal Article
Open access
PDF file
VBValentin Barthet
Valentin Barthet
MBMartina Brucoli
Martina Brucoli
MLMarcus J. G. W. Ladds
Marcus J. G. W. Ladds
CNChristoph Nössing
Christoph Nössing
CKChristos Kiourtis
Christos Kiourtis
KRKevin M. Ryan
Kevin M. Ryan
Autophagy represses YAP/TAZ-dependent hepatocyte dedifferentiation into liver progenitor cells to prevent tumorigenesis.

6 July 2022 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
JLJaclyn S. Long
Jaclyn S. Long
EKElżbieta Kania
Elżbieta Kania
DMDavid G. McEwan
David G. McEwan
VBValentin Barthet
Valentin Barthet
MBMartina Brucoli
Martina Brucoli
KRKevin M. Ryan
Kevin M. Ryan
The role of autophagy in cancer is complex. Both tumor-promoting and tumor-suppressive effects are reported, with tumor type, stage and specific genetic lesions dictating the role. This calls for analysis in models that best recapitulate each tumor type, from initiation to metastatic disease, to specifically understand the contribution of autophagy in each context. Here, we report the effects of deleting the essential autophagy gene Atg7 in a model of pancreatic ductal adenocarcinoma (PDAC), in which mutant Kras G12D and mutant Trp53 172H are induced in adult tissue leading to metastatic PDAC. This revealed that Atg7 loss in the presence of Kras G12D /+ and Trp53 172H /+ was tumor promoting, similar to previous observations in tumors driven by embryonic Kras G12D /+ and deletion of Trp53 . However, Atg7 hemizygosity also enhanced tumor initiation and progression, even though this did not ablate autophagy. Moreover, despite this enhanced progression, fewer Atg7 hemizygous mice had metastases compared with animals wild type for this allele, indicating that ATG7 is a promoter of metastasis. We show, in addition, that Atg7 +/− tumors have comparatively lower levels of succinate, and that cells derived from Atg7 +/− tumors are also less invasive than those from Atg7 +/+ tumors. This effect on invasion can be rescued by ectopic expression of Atg7 in Atg7 +/− cells, without affecting the autophagic capacity of the cells, or by treatment with a cell-permeable analog of succinate. These findings therefore show that ATG7 has roles in invasion and metastasis that are not related to the role of the protein in the regulation of autophagy.

13 January 2026 in Cancer Letters
Verified
Journal Article
Open access
IPIsabella Prantl
Isabella Prantl
RGReinhard Grausenburger
Reinhard Grausenburger
JMJulia Müller
Julia Müller
OBOliver Baumfried
Oliver Baumfried
IEIris Elisabeth Ertl
Iris Elisabeth Ertl
BEBernhard Englinger
Bernhard Englinger

7 April 2026 in Molecular Cell
Verified
Journal Article
Open access
CNChristoph Nössing
Christoph Nössing
OTOlga Troitskaya
Olga Troitskaya
JLJaclyn S. Long
Jaclyn S. Long
ACAndrew Craxton
Andrew Craxton
MBMartina Brucoli
Martina Brucoli
KRKevin M. Ryan
Kevin M. Ryan
Inflammation can affect many diseases. We report here that inflammatory cytokines invoke caspase-8-mediated cleavage of the autophagy adaptor p62/SQSTM1 at aspartic acid 329 in human cells, producing a previously described truncated form, which we term tr-p62. We show that TNF-driven cell death is tr-p62 dependent and that autophagy inhibition promotes death via tr-p62 accumulation. Mechanistically, p62 cleavage is receptor-interacting serine/threonine-protein kinase 1 (RIPK1) dependent, and tr-p62 stabilizes caspase-8 activating complex-IIb. tr-p62-driven cell death downstream of TNF is also RIPK1 and caspase dependent, promoting feedforward caspase-8 activation. p62 cleavage does not, however, affect necroptosis. Surprisingly, this caspase-8 cleavage site in p62 is absent in mice, and introduction of cleavable forms of p62 into mouse cells causes sensitization to TNF-induced death. Moreover, mice with CRISPR-Cas9-generated cleavable p62 exhibit TNF hypersensitivity and intestinal inflammation in vivo. These findings provide significant insights into TNF-induced cell death and introduce a mouse model that may provide better clarity for human-related studies of inflammatory disease.

14 June 2026 in Autophagy
Verified
Journal Article
Closed access
OTOlga Troitskaya
Olga Troitskaya
CNChristoph Nössing
Christoph Nössing
KRKevin M. Ryan
Kevin M. Ryan
Macroautophagy (hereafter referred to as autophagy) plays a key role in maintaining cellular homeostasis and shaping response to stress and inflammation. We outline here that inflammatory cytokines trigger caspase-8-dependent cleavage of the autophagy adaptor protein p62/SQSTM1 at aspartic acid 329 generating a truncated form (tr-p62). Tr-p62 enhanced TNF-induced cell death by stabilizing the RIPK1-dependent complex-IIb and amplifying caspase-8 activation, while having no detectable effect on necroptosis. Blocking autophagy leads to tr-p62 accumulation and increased TNF-induced cell death, while non-cleavable p62 reduced autophagic responses and TNF sensitivity. Interestingly, mice naturally lack the caspase-8 cleavage site in p62 and restoring a cleavable version of p62 sensitized mouse cells to TNF-induced cell death. In addition, mice with cleavable p62 showed heightened sensitivity to TNF-induced toxic shock and chemical colitis in vivo. These findings identify p62 cleavage as a key regulator linking autophagy to TNF-driven inflammatory cell death and highlight an important species-specific difference that may influence the interpretation of inflammatory disease models.Abbreviation: DSS: dextran sulfate sodium; FADD: Fas-associated death domain protein; LC3: microtubule-associated protein 1A/1B-light chain 3; PROTAC: proteolysis-targeting chimera; RIPK1: receptor-interacting serine/threonine-protein kinase 1; SMAC: second mitochondria-derived activator of caspases; TNF: tumour necrosis factor; TRAIL: TNF-related apoptosis-inducing ligand.